Covid-19: Biomedical Perspectives
- 1st Edition, Volume 50 - May 24, 2022
- Imprint: Academic Press
- Editors: Charles S. Pavia, Volker Gurtler
- Language: English
- Hardback ISBN:9 7 8 - 0 - 3 2 3 - 8 5 0 6 1 - 2
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 8 5 3 4 0 - 8
Covid-19: Biomedical Perspectives, Volume 50 in the Methods in Microbiology series highlights new advances in the field, with this new volume presenting interesting chapters writ… Read more
Purchase options
Covid-19: Biomedical Perspectives, Volume 50 in the Methods in Microbiology series highlights new advances in the field, with this new volume presenting interesting chapters written by an international board of authors. Individual chapters in this new release include Sensitive methods for detection of SARS-CoV-2 RNA, Treatment of COVID-19 using Chinese herbal medicine, Understanding how SARS-CoV-2 is evolving and its impact on COVID-19 animal models and vaccine evaluation, Methods in machine learning to identify COVID-19 literature, COVID-19 seasonal behavior and the mutational landscape of the SARS-CoV-2 virus, CRISPR use in Diagnosis and Therapy for COVID-19, and much more.
- Provides the authority and expertise of leading contributors from an international board of authors
- Presents the latest release in Methods of Microbiology serials
- Updated release includes the latest information on Covid-19: Biomedical Perspectives
Undergraduates, graduates, academics, and researchers in the field of microbiology
Preface
Volker Gűrtler and Charles Pavia
1. Sensitive methods for detection of SARS-CoV-2 RNA
Xi Chen and Simin Xia
2. Treatment of COVID-19 using Chinese herbal medicine
William Cho
3. Understanding how SARS-CoV-2 is evolving and its impact on COVID-19 animal models and vaccine evaluation
Seshadri S. Vasan
4. Methods in machine learning to identify COVID-19 literature
Anhvinh Doanvo
5. COVID-19 seasonal behavior and the mutational landscape of the SARS-CoV-2 virus
Gustavo Caetano-Anolles
6.
Afsar Raza Naqvi
7. CRISPR use in Diagnosis and Therapy for COVID-19
Yashpal Singh Malik, Pallavi Deol and Rahul Kaushik
8.
Kuldeep Dhama
9. Recent and advanced nanotechnological strategies for COVID-19 vaccine development
Chinekwu Sherridan Nwagwu
10. A review of hypersensitivity methods to measure cellular immune responses to SARS-CoV-2
Victor Matheu and Yvelise Barrios
11. Role of mRNA technology and gene silencing in manufacturing vaccines against SARS-CoV-2
Pratik Talukder
12. Hesitancy to get vaccinated against COVID-19 and how it might be overcome
Charles Pavia
- Edition: 1
- Volume: 50
- Published: May 24, 2022
- Imprint: Academic Press
- Language: English
CP
Charles S. Pavia
Dr. Pavia is a Microbiologist/Immunologist and an Associate Professor at the NYIT College of Osteopathic Medicine in Old Westbury, New York. He is also an Adjunct Associate Professor at New York Medical College. He previously worked and held research appointments at the Trudeau Institute in Saranac Lake, NY, and the Walter Reed Army Institute for Research in Washington, DC. Throughout his career, he has focused his research activities on various pathogenic microbes with a particular emphasis on the disease-causing spirochetes and certain protozoan pathogens. His research has covered multiple areas including the basic microbiologic, immunologic, molecular, diagnostic and clinical aspects of Lyme disease, syphilis, malaria and toxoplasmosis. He has published widely on these areas in peer-reviewed journals, as well as given numerous research presentations of his work at national and international conferences. As a principal investigator or co-investigator, he has received research funding from the NIH, the CDC, the J.M. Foundation, and various other organizations to support his research work. He has been a member of the editorial board of the Journal of Microbiological Methods for the past 25 years, and has been an ad-hoc reviewer for a wide range of other scientific journals.
Affiliations and expertise
Associate Professor, NYIT College of Osteopathic Medicine, USAVG
Volker Gurtler
Dr Gurtler is a Molecular biologist with extensive industry experience and expertise in DNA analysis for the identification and typing of organisms. He is known internationally as the author of the original methodology of ribotyping. He is Advisor to Geneious (Bioinformatics software company) and previous head of Molecular Biology at Austin Health Microbiology, currently Adjunct Professor at RMIT University, Editor of Journal of Microbiological Methods, Editor of Heliyon and Series Editor of Methods in Microbiology. Dr Gurtler is currently working in collaboration with Assoc. Prof Danilla Grando on ribosome analysis of E. coli isolates and association with virulence. He visits RMIT regularly to advise on experimental methods and help PhD students use Geneious Bioinformatic software.
Affiliations and expertise
Adjunct Professor, RMIT University, Melbourne, AustraliaRead Covid-19: Biomedical Perspectives on ScienceDirect